Intestinal lymphoma perforations as a consequence of highly effective anti-CD20 antibody therapy
Authors:
- Otto KollmarOKOtto Kollmar
- Sandra BeckerSBSandra Becker
- Martin K. SchillingMSMartin K. Schilling
- Christoph A. MaurerCMChristoph A. Maurer
- 1 February 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 73 (4) , 669-670
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three casesJournal of Hepatology, 2000
- The Involvement of the Gastrointestinal Tract in Posttransplant Lymphoproliferative Disease in Pediatric Liver TransplantationJournal of Pediatric Gastroenterology and Nutrition, 1999
- POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND GASTROINTESTINAL MANIFESTATIONS OF EPSTEIN-BARR VIRUS INFECTION IN CHILDREN FOLLOWING LIVER TRANSPLANTATIONTransplantation, 1998
- Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic DrugsCancer Biotherapy and Radiopharmaceuticals, 1997